Rt-PA in the Treatment of Acute Ischemic Stroke


Phase 3 Results

Summary of Purpose

To collect additional confirmatory data on alteplase(rt-PA) in the European setting and to demonstrate that the treatment of patients between 3 and 4.30 hours of onset of symptoms of acute ischemic stroke with rt-PA compared to placebo-treated patients will result in an improved clinical outcome without increase of fatality rate.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 April 2014.

1 Apr 2003 9 Sep 2005 1 Feb 2008 Unavailable 1 Apr 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Purpose: Treatment


  • Bertrand Baumelou, MD Head of Clinical Research Unit Neurovascular, Immunology, Virology BI France 12, Rue André Huet, BP 292 F-51060 Reims cedex Tel: 00 33 326 50 87 04 Fax: 00 33 326 50 38 39